MRNAON
MRNAON is the Ondo tokenized version of Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses, latent viral infections and public health threats. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions.
Nombre MRNAON
Puesto No.
Cap. de mercado $0.00
Cap. de mercado totalmente diluida $0.00
Cuota de mercado %
Vol. de operaciones/Cap. de mercado (24 h) 0
Suministro de circulación --
Suministro máx. 0
Suministro total --
Tasa de circulación %
Fecha de emisión --
El precio al que el activo fue emitido por primera vez --
Máximo histórico ,
Precio más bajo ,
Blockchain pública MRNAON
Introducción MRNAON is the Ondo tokenized version of Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses, latent viral infections and public health threats. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions.
Sector
- common.mc-trade-zone-xStocks
Redes sociales
Análisis de flujo de fondos
|
Comprar(MRNAON) |
Vender(MRNAON) |
Ingresos netos |
| Grande |
0.000 |
0.000 |
0.000 |
| Mediana |
0.000 |
0.000 |
0.000 |
| Pequeña |
3.383 |
4.885 |
-1.502 |
| Total |
3.383 |
4.885 |
-1.502 |
Aviso de riesgos: Los datos proporcionados por no deben considerarse como asesoramiento de inversión.